Skip to main content

Carcinogen-DNA Adducts as Tools in Risk Assessment

  • Chapter
Advances in Nutrition and Cancer 2

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 472))

Abstract

Effective strategies for preventing human cancer resulting from exposure to chemical carcinogens of environmental, occupational or life-style sources, require the identification of the carcinogens to which people are exposed and the evaluation of the degree of exposure. The use of biological markers to detect such exposure and the early events in the process of carcinogenesis has increased greatly in recent years and their use is expected to be of help for the assessment of future disease risk.1–3

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Perera, F.P. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J. Natl. Cancer Inst., 88: 496–509, 1996.

    Article  PubMed  CAS  Google Scholar 

  2. La, D.K. and Swenberg, J.A. DNA adducts: biological markers of exposure and potential applications to risk assessment. Mutat. Res., 365: 129–146, 1996.

    Article  PubMed  Google Scholar 

  3. Dale, C.M. and Garner, R.C. Measurement of DNA adducts in humans after complex mixture exposure. Food Chem. Toxicol., 34: 905–919, 1996.

    Article  PubMed  CAS  Google Scholar 

  4. Miller, E.C. and Miller, J.A. Mechanisms of chemical carcinogenesis. Cancer, 47: 1055–1064, 1981.

    Article  PubMed  CAS  Google Scholar 

  5. Wogan, G.N. Molecular epidemiology in cancer risk assessment and prevention: Recent progress and avenues for future research. Environ. Health Perspect., 98: 167–178, 1992.

    Article  Google Scholar 

  6. Skipper, P.L. and Tannenbaum, S.R. Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis, 11: 507–518, 1990.

    Article  PubMed  CAS  Google Scholar 

  7. Harris, C.C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res., 51: 5023s - 5044s, 1991.

    PubMed  CAS  Google Scholar 

  8. Swenberg, J.A., Fedtke, N., Fennell, T.R., and Walker, V.E. Relationships between carcinogen exposure, DNA adducts and carcinogenesis. In: D.B. Clayson, I.C. Munro, P. Shubik, and J.A. Swenberg (eds.), Progress in Predictive Toxicology, pp. 161–184, Amsterdam: Elsevier. 1990.

    Google Scholar 

  9. Brookes, P. and Lawley, P.D. Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of the hydrocarbons and their binding to deoxyribonucleic acid. Nature, 202: 781–784, 1964.

    Article  PubMed  CAS  Google Scholar 

  10. Lutz, W.K. Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens. J. Cancer Res. Clin. Oncol., 112: 85–91, 1986.

    Google Scholar 

  11. Poirier, M.C. The use of carcinogen-DNA adduct antisera for quantitation and localization of genomic damage in animal models and the human population. Environ. Mutagen., 6: 879–887, 1984.

    Article  PubMed  CAS  Google Scholar 

  12. Wogan, G.N. and Gorelick, N.J. Chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ. Health Perspect., 62: 5–18, 1985.

    Article  PubMed  CAS  Google Scholar 

  13. Nesnow, S., Ross, J.A., Mass, M.J., and Stoner, G.D. Mechanistic relationships between DNA adducts, oncogene mutations, and lung tumorigenesis in strain A mice. Exp. Lung Res., 24: 395–405, 1998.

    Article  PubMed  CAS  Google Scholar 

  14. Denissenko, M.F., Pao, A., Tang, M., and Pfeifer, G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science, 274: 430–432, 1996.

    Article  PubMed  CAS  Google Scholar 

  15. Gupta, R.C. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl. Acad. Sci. USA, 81: 6943–6947, 1984.

    Article  Google Scholar 

  16. Dipple, A. DNA adducts of chemical carcinogens. Carcinogenesis, 16: 437–441, 1995.

    Article  PubMed  CAS  Google Scholar 

  17. Loveless, A. Possibile relevance of O-6 alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides. Nature, 223: 206–207, 1969.

    Article  PubMed  CAS  Google Scholar 

  18. Singer, B. N-nitroso alkylating agents: formation and persistence of alkyl derivatives in mammalian nucleic acids as contributing factors in carcinogenesis. J. Natl. Cancer Inst., 62: 1329–1339, 1979.

    PubMed  CAS  Google Scholar 

  19. Saffhill, R., Margison, G.P., and O’Connor, P.J. Mechanisms of carcinogenesis induced by alkylating agents. Biochim. Biophys. Acta, 823: 111–145, 1985.

    PubMed  CAS  Google Scholar 

  20. Jerina, D.M., Chadha, A., Cheh, A.M., Schurdak, M.E., Wood, A.W., and Sayer, J.M. Covalent binding of bay-region diol epoxides to nucleic acids. Adv. Exp. Med. Biol., 283: 533–553, 1991.

    Article  PubMed  CAS  Google Scholar 

  21. Jernstrom, B. and Graslund, A. Covalent binding of benzo[a]pyrene 7,8-dihydrodiol 9,10-epoxides to DNA: molecular structures, induced mutations, and biological consequences. Biophys. Chem., 49: 185–199, 1994.

    Article  PubMed  CAS  Google Scholar 

  22. Humphreys, W.G., Kadlubar, F.F., and Guengerich, F.P. Mechanism of C8 alkylation of guanine residues by activated arylamines: evidence for initial adduct formation at the N7 position. Proc. Natl. Acad. Sci. USA, 89: 8278–8282, 1992.

    Article  PubMed  CAS  Google Scholar 

  23. Essigmann, J.M., Croy, R.G., Nadzan, A.M., Busby, W.F.,Jr., Reinhold, V.N., Buchi, G., and Wogan, G.N. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc. Natl. Acad. Sci. USA, 74: 1870–1874, 1977.

    CAS  Google Scholar 

  24. Croy, R.G., Essigmann, J.M., Reinhold, V.N., and Wogan, G.N. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. Proc. Natl. Acad. Sci. USA, 75: 1745–1749, 1978.

    Article  PubMed  CAS  Google Scholar 

  25. Phillips, D.H., Hemminki, K., Alhonen, A., Hewer, A., and Grover, P.L. Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNA adducts in white blood cells of iron foundry workers. Mutat. Res., 204: 531–541, 1988.

    Article  PubMed  CAS  Google Scholar 

  26. Cuzick, J., Routledge, M.N., Jenkins, D., and Garner, R.C. DNA adducts in different tissues of smokers and non-smokers. Int. J. Cancer, 45: 673–678, 1990.

    Article  PubMed  CAS  Google Scholar 

  27. Talaska, G., Schamer, M., Skipper, P, Tannenbaum, S., Caporaso, N., Unruh, L., Kadlubar, PF., Bartsch, H., Malaveille, C., and Vineis, P Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol. Biomarkers. Prey., 1: 61–66, 1991.

    CAS  Google Scholar 

  28. Hsu, T.M., Zhang, Y.J., and Santella, R.M. Immunoperoxidase quantitation of 4-aminobiphenyl-and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol. Biomarkers. Prev., 6: 193–199, 1997.

    CAS  Google Scholar 

  29. Talaska, G., al-Juburi, A.Z., and Kadlubar, F.F. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. USA, 88: 5350–5354, 1991.

    Article  PubMed  CAS  Google Scholar 

  30. Arnould, J.P, Verhoest, P., Bach, V., Libert, J.P., and Belegaud, J. Detection of benzo[a]pyrene-DNA adducts in human placenta and umbilical cord blood. Hum. Exp. Toxicol., 16: 716–721, 1997.

    Article  CAS  Google Scholar 

  31. Shuker, D.E.G. and Farmer, P.B. Relevance of urinary DNA adducts as markers of carcinogen exposure. Chem. Res. Toxicol., 5: 450–460, 1992.

    Article  PubMed  CAS  Google Scholar 

  32. Groopman, J.D., Donahue, P.R., Zhu, J.Q., Chen, J.S., and Wogan, G.N. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc. Natl. Acad. Sci. USA, 82: 6492–6496, 1985.

    Article  PubMed  CAS  Google Scholar 

  33. Gupta, R.C., Reddy, M.V., and Randerath, K. 32P-postlabeling analysis of non-radioactive aromatic carcinogen—DNA adducts. Carcinogenesis, 3: 1081–1092, 1982.

    Article  PubMed  CAS  Google Scholar 

  34. Gupta, R.C. 32P-postlabelling analysis of bulky aromatic adducts. IARC Sci. Publ., 124: 11–23, 1993.

    CAS  Google Scholar 

  35. Beach, A.C. and Gupta, R.C. Human biomonitoring and the 32P-postlabeling assay. Carcinogenesis, 13: 1053–1074, 1992.

    Article  PubMed  CAS  Google Scholar 

  36. Reddy, M.V. and Randerath, K. Nuclease Pl-mediated enhancement of sensitivity of 32Ppostlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7: 1543–1551, 1986.

    Article  PubMed  CAS  Google Scholar 

  37. Levy, G.N. and Weber, W.W. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts. Anal. Biochem., 174: 381–392, 1988.

    Article  PubMed  CAS  Google Scholar 

  38. Poirier, M.C. Human exposure monitoring, dosimetry, and cancer risk assessment: the use of antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA. Drug Metab. Rev., 26: 87–109, 1994.

    CAS  Google Scholar 

  39. Strickland, P.T. and Boyle, J.M. Immunoassay of carcinogen-modified DNA. Prog. Nucleic Acid Res. Mol. Biol., 31: 1–58, 1984.

    Article  PubMed  CAS  Google Scholar 

  40. Kriek, E., Den Engelse, L., Scherer, E., and Westra, J.G. Formation of DNA modifications by chemical carcinogens. Identification, localization, and quantification. Biochim. Biophys. Acta, 738: 181–201, 1984.

    PubMed  CAS  Google Scholar 

  41. Harris, C.C., Yolken, R.H., and Hsu, I-C. Enzyme immunoassays: applications in cancer research. In: H. Busch and L.C. Yeoman (eds.), Methods in Cancer Research, Vol. XX, pp. 213–243, New York: Academic Press. 1982.

    Google Scholar 

  42. Hsu, I.C., Poirier, M.C., Yuspa, S.H., Grunberger, D., Weinstein, I.B., Yolken, R.H., and Harris, C.C. Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. Cancer Res., 41: 1091–1095, 1981.

    PubMed  CAS  Google Scholar 

  43. King, M.M., Cuzick, J., Jenkins, D., Routledge, M.N., and Garner, R.C. Immunoaffinity concentration of human lung DNA adducts using an anti-benzo[a]pyrene-diol-epoxide-DNA antibody. Analysis by 32P-postlabelling or ELISA. Mutat. Res., 292: 113–122, 1993.

    Article  PubMed  CAS  Google Scholar 

  44. Airoldi, L., Magagnotti, C., Chiappetta, L., Bonfanti, M., Pastorelli, R., and Fanelli, R. Simultaneous immunoaffinity purification of 06-methyl, 06-ethyl-, 06-propyl-and, 06-butylguanine and their analysis by gas chromatography/mass spectrometry. Carcinogenesis, 16: 2247–2250, 1995.

    Article  PubMed  CAS  Google Scholar 

  45. Pastorelli, R., Guanci, M., Cerri, A., Negri, E., La Vecchia, C., Fumagalli, F, Mezzetti, M., Cappelli, R., Panigalli, T., Fanelli, R., and Airoldi, L. Impact of inherited polymorphisms in glutathione S-transferase Ml, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol. Biomarkers. Prev., 7: 703–709, 1998.

    CAS  Google Scholar 

  46. Vahakangas, K., Haugen, A., and Harris, C.C. An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adducts. Carcinogenesis, 6: 1109–1115, 1985.

    Article  PubMed  CAS  Google Scholar 

  47. Autrup, H., Bradley, K.A., Shamsuddin, A.K.M., Wakhisi, J., and Wasunna, A. Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7’-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang’a district, Kenya. Carcinogenesis, 4: 1193–1195, 1983.

    Article  CAS  Google Scholar 

  48. Autrup, H., Wakhisi, J., Vahakangas, K., Wasunna, A., and Harris, C.C. Detection of 8,9-dihydro-(7’guanyl)-9-hydroxyaflatoxin B1 in human urine. Environ. Health Perspect., 62: 105–108, 1985.

    PubMed  CAS  Google Scholar 

  49. Sanders, M.J., Cooper, R.S., Jankowiak, R., Small, G.J., Heisig, V., and Jeffrey, A.M. Identification of polycyclic aromatic hydrocarbon metabolites and DNA adducts in mixtures using fluorescence line narrowing spectrometry. Anal. Chem., 58: 816–820, 1986.

    Article  PubMed  CAS  Google Scholar 

  50. Strickland, P.T., Routledge, M.N., and Dipple, A. Methodologies for measuring carcinogen adducts in humans. Cancer Epidemiol. Biomarkers Prev., 2: 607–619, 1993.

    CAS  Google Scholar 

  51. Farmer, P.B., Bailey, E., Naylor, S., Anderson, D., Brooks, A., Cushnir, J., Lamb, J.H., Sepai, O., and Tang, Y.S. Identification of endogenous electrophiles by means of mass spectrometric determination of protein and DNA adducts. Environ. Health Perspect., 99: 19–24, 1993.

    Article  PubMed  CAS  Google Scholar 

  52. Lin, D., Lay, J.O.,Jr., Bryant, M.S., Malaveille, C., Friesen, M., Bartsch, H., Lang, N.P., and Kadlubar, F.F. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ. Health Perspect., 102 Suppl 6: 11–16, 1994.

    Google Scholar 

  53. Friesen, M.D., Kaderlik, K., Lin, D., Garren, L., Bartsch, H., Lang, N.P., and Kadlubar, F.F. Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/electron capture mass spectrometry: Validation by comparison with 32P-postlabeling. Chem. Res. Toxicol., 7: 733–739, 1994.

    Article  PubMed  CAS  Google Scholar 

  54. Kambouris, S.J., Chaudhary, A.K., and Blair, I.A. Liquid chromatography/electrospray ionization tandem mass spectroscopy (LC/ESI MS/MS) analysis of 1,2-epoxybutene adducts of purine deoxynucleosides. Toxicology, 113: 331–335, 1996.

    Article  PubMed  CAS  Google Scholar 

  55. Tang, D., Santella, R.M., Blackwood, A.M., Young, T.-L., Mayer, J., Jaretzki, A., Grantham, S., Tsai, W-Y., and Perera, F.P. A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol. Biomarkers Prey., 4: 341–346, 1995.

    CAS  Google Scholar 

  56. Peluso, M., Airoldi, L., Armelle, M., Martone, T., Coda, R., Malaveille, C., Giacomelli, G., Terrone, C., Casetta, G., and Vineis, R White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study. Cancer Epidemiol. Biomarkers Prey., 7: 341–346, 1998.

    CAS  Google Scholar 

  57. Ross, R.K., Yuan, J.-M., Yu, M.C., Wogan, G.N., Qian, G.-S., Tu, J.-T., Groopman, J.D., Gao, Y.-T., and Henderson, B.E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339: 943–946, 1992.

    Article  PubMed  CAS  Google Scholar 

  58. Qian, G.-S., Ross, R.K., Yu, M.C., Yuan, J.-M., GaoY.-T., Henderson, B.E., Wogan, G.N., and Groopman, J.D. A follow-up study of urinary markers of afiatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiol. Biomarkers Prey., 3: 3–10, 1994.

    CAS  Google Scholar 

  59. Binkova, B., Topinka, J., Mrackova, G., Gajdosova, D., Vidova, R, Stavkova, Z., Pilcik, RV., Rimar, V., Dobias, L., Farmer, P.B., and Sram, R.J. Coke oven workers study: the effect of exposure and GSTM1 and NAT2 genotypes on DNA adduct levels in white blood cells and lymphocytes as determined by 32P-postlabelling. Mutat. Res., 416: 67–84, 1998.

    Article  PubMed  CAS  Google Scholar 

  60. Peluso, M., Merlo, E, Munnia, A., Valerio, E, Perrotta, A., Puntoni, R., and Parodi, S. 32P-postlabeling detection of aromatic adducts in the white blood cell DNA of nonsmoking police officers. Cancer Epidemiol. Biomarkers Prey., 7: 3–11, 1998.

    Google Scholar 

  61. Van Schooten, FJ., Godschalk, R.W.L., Breedijk, A., Maas, L.M., Kriek, E., Sakai, H., Wigbout, G., Baas, R, Van’tVeer, L., and van Zandwijk, N. 32P-postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures. Mutat. Res., 378: 65–75, 1997.

    Google Scholar 

  62. Hemminki, K., Dickey, C., Karlsson, S., Bell, D., Hsu, Y., Tsai, W.-Y., Mooney, L.A., Savela, K., and Perera, F.P. Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis, 18: 345–350, 1997.

    Article  PubMed  CAS  Google Scholar 

  63. Mooney, L.A., Bell, D.A., Santella, R.M., Van Bennekum, A.M., Ottman, R., Paik, M., Blaner, W.S., Lucier, G.W., Covey, L., Young, T.-L., Cooper, T.B., and Glassman, A.H. Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis, 18: 503–509, 1997.

    Article  PubMed  CAS  Google Scholar 

  64. Rojas, M., Alexandrov, K., Cascorbi, I., Brockmöller, J., Likhachev, A., Pozharisski, K., Bouvier, G., Auburtin, G., Mayer, L., Kopp-Schneider, A., Roots, I., and Bartsch, H. High benzo[a]pyrene diolepoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1 *0/*0 genotypes. Pharmacogenetics, 8: 109–118, 1998.

    Article  PubMed  CAS  Google Scholar 

  65. Martone, T., Airoldi, L., Magagnotti, C., Coda, R., Randone, D., Malaveille, C., Avanzi, G., Merletti, E, Hautefeuille, A., and Vineis, P. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer. Int. J. Cancer, 75: 512–516, 1998.

    Article  PubMed  CAS  Google Scholar 

  66. Culp, S.J., Roberts, D.W., Talaska, G., Lang, N.P., Fu, P.P., Lay, J.O.Jr., Teitel, C.H., Snawder, J.E., Von Tungeln, L.S., and Kadlubar, F.F. Immunochemical, 32P-postlabeling, and GC/MS detection of 4aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Mutat. Res., 378: 97–112, 1997.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Airoldi, L., Pastorelli, R., Magagnotti, C., Fanelli, R. (1999). Carcinogen-DNA Adducts as Tools in Risk Assessment. In: Zappia, V., Della Ragione, F., Barbarisi, A., Russo, G.L., Iacovo, R.D. (eds) Advances in Nutrition and Cancer 2. Advances in Experimental Medicine and Biology, vol 472. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3230-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3230-6_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-3331-7

  • Online ISBN: 978-1-4757-3230-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics